(NASDAQ: XRAY) Dentsply Sirona's forecast annual revenue growth rate of -0.07% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.37%.
Dentsply Sirona's revenue in 2025 is $3,793,000,000.On average, 9 Wall Street analysts forecast XRAY's revenue for 2025 to be $709,356,998,088, with the lowest XRAY revenue forecast at $702,950,053,855, and the highest XRAY revenue forecast at $712,946,415,117. On average, 9 Wall Street analysts forecast XRAY's revenue for 2026 to be $728,793,140,090, with the lowest XRAY revenue forecast at $721,564,757,034, and the highest XRAY revenue forecast at $743,752,360,909.
In 2027, XRAY is forecast to generate $754,705,873,512 in revenue, with the lowest revenue forecast at $739,653,126,471 and the highest revenue forecast at $770,357,586,362.